A novel EIF4A3/m6A-circPCMTD1/miR-3681-5p/HPSE/PI3K/AKT axis is identified and suggests potential therapeutic targets for BCa.
Abstract
Background
Bladder cancer (BCa) is a common urological malignancy with high recurrence rates and limited treatment options for advanced disease. Circular RNAs (circRNAs) are emerging as key regulators of cancer progression, but the roles of most circRNAs in BCa remain poorly understood.
Objective
To investigate the expression, function and mechanism of circPCMTD1 (hsa_circ_0001801) in BCa, focusing on its m6A methylation and its role as a ceRNA regulating the miR-3681-5p/HPSE/PI3K/AKT axis.
Methods
circPCMTD1 expression was analyzed in GEO datasets, 30 paired BCa tissues and cell lines by qRT-PCR. Circular structure and stability were confirmed by RNase R and actinomycin D assays. Subcellular localisation was determined by fractionation and FISH. Gain- and loss-of-function experiments assessed circPCMTD1 effects on BCa cell malignancy. A subcutaneous xenograft model was used for in vivo validation. m6A sites were predicted by SRAMP, and circPCMTD1-EIF4A3 interaction validated by RIP. Protein-protein docking predicted EIF4A3-METTL3 binding. miRNA targets were screened by ENCORI and confirmed by qRT-PCR and RNA-FISH. miR-3681-5p targets were identified by transcriptome sequencing and database analysis. Western blotting assessed HPSE, PI3K, AKT and p-AKT. Rescue experiments verified the circPCMTD1/miR-3681-5p/HPSE axis.
Results
circPCMTD1 was upregulated in BCa tissues and cells, stable and cytoplasmic. Knockdown suppressed BCa proliferation, migration, invasion and Tumor growth in vivo, while overexpression promoted these phenotypes. circPCMTD1 contained nine predicted m6A sites, interacted with EIF4A3, and EIF4A3 docked with METTL3. circPCMTD1 overexpression increased METTL3, METTL14, FTO and YTHDF2. circPCMTD1 directly sponged miR-3681-5p. miR-3681-5p acted as a tumor-suppressive miRNA. HPSE was a direct target of miR-3681-5p and overexpressed in BCa. circPCMTD1 positively regulated HPSE, PI3K and p-AKT, whereas miR-3681-5p had opposite effects. Rescue experiments confirmed that circPCMTD1 promoted BCa through sponging miR-3681-5p and activating HPSE/PI3K/AKT.
Conclusions
EIF4A3 facilitates METTL3-mediated m6A methylation of circPCMTD1. Methylated circPCMTD1 acts as a ceRNA sponging miR-3681-5p, derepressing HPSE and activating PI3K/AKT to drive BCa progression. This study identifies a novel EIF4A3/m6A-circPCMTD1/miR-3681-5p/HPSE/PI3K/AKT axis and suggests potential therapeutic targets for BCa.
A potential oncogenic pathway was delineated in which NPC migration and invasion were facilitated by YTHDF2 via degradation of circ_0015508, thereby the sponging effect of miR-496 was abolished and FOXN3 expression was suppressed.
Ai-Yu Ma, Xu Wang, Lu Lu et al.· Oncology Research· 0 citations
Skin cutaneous melanoma (SKCM) is a highly aggressive malignancy with a poor prognosis, necessitating the exploration of novel molecular mechanisms driving its progression. CircRNA, which have emerged as critical regulators in cancer biology, have been implicated in various tumorigenic processes. However, their specifi...
Ronghua Yang, Xiaoxiang Wang, Jia-Nan Zhuo et al.· Journal of Translational Med...· 0 citations
Findings indicate that circ_0001495 may serve as a potential diagnostic/prognostic biomarker for BCa and promotes tumor progression by activating the miR-1184/MAPK signaling axis.
BACKGROUND
Circular RNA (circRNA) has been recognized as critical regulator in cancer progression. However, the mechanisms of circ_0081069 in breast cancer (BC) remain understood. The study was designed to elucidate the pathological significance and mechanism of circ_0081069 in BC.
MATERIAL AND METHODS
The expression...
Jinghui Peng, Yue Huang, Wen-Tong Fang et al.· Immunopharmacology and immun...· 0 citations
Clinically, these findings not only deepen the understanding of m6A-mediated posttranscriptional regulation in CRC but also identify this axis as a promising therapeutic target for overcoming ferroptosis resistance and improving patient outcomes.
Li-Chun Wang, Bin Guo, Xue-Ping Jiao et al.· Current Gene Therapy· 0 citations
MCM10 is aberrantly overexpressed in CRC and linked to worse clinical outcomes and its oncogenic effects involve METTL3/YTHDF1-mediated mRNA stabilization and enhanced M2 macrophage polarization, suggesting a potential role in immune microenvironment modulation.
Qiao Qu, Zhilong Li, Da-Lu Wang et al.· Cellular and Molecular Life...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.